- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/32 - Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
Patent holdings for IPC class C07D 237/32
Total number of patents in this class: 235
10-year publication summary
|
24
|
26
|
18
|
11
|
20
|
15
|
15
|
25
|
12
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MetrioPharm AG | 48 |
16 |
| Bristol-myers Squibb Company | 4875 |
9 |
| KuDOS Pharmaceuticals Limited | 37 |
6 |
| Flatley Discovery Lab, LLC | 19 |
6 |
| Abbvie Inc. | 1803 |
5 |
| Mirati Therapeutics, Inc. | 247 |
5 |
| The Trustees of the University of Pennsylvania | 4315 |
4 |
| Chugai Seiyaku Kabushiki Kaisha | 1338 |
4 |
| Gilead Sciences, Inc. | 2027 |
4 |
| ScinoPharm Taiwan, Ltd. | 127 |
4 |
| Nuformix Technologies Limited | 12 |
4 |
| Boehringer Ingelheim International GmbH | 4698 |
3 |
| Janssen Pharmaceutica N.V. | 3413 |
3 |
| Monsanto Technology LLC | 8133 |
3 |
| AbbVie Deutschland GmbH & Co. KG | 260 |
3 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Addex Pharma SA | 62 |
3 |
| Arbutus Biopharma Corporation | 177 |
3 |
| Chengdu Di'ao Pharmaceutical Group Co., Ltd. | 20 |
3 |
| Denali Therapeutics Inc. | 240 |
3 |
| Other owners | 141 |